D-1167-2014 Class III Terminated
FDA drug recall D-1167-2014 was initiated by McKesson Packaging Services on Mar 3, 2014 and is designated Class III. Reason for recall: Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval. The recall status is terminated (terminated Aug 14, 2014). Affected quantity: 1,557 Boxes.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 26, 2014
- Initiation Date
- Mar 3, 2014
- Termination Date
- Aug 14, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,557 Boxes
Product description
Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10
Reason for recall
Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.
Distribution pattern
Nationwide
Code information
Lot #: 91357
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1167-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026